Newborn Sickle Screening|
Accredited to ISO/IEC 17043:2010, Provider 7805
Detection of Sickle Haemoglobin and other clinically significant haemoglobin variants using dried blood spot specimens
PURPOSE OF PROGRAMME:
To monitor the performance of participants screening dried blood spot specimens for the presence of sickle haemoglobin and other clinically significant haemoglobin variants.
|Identification of sickle haemoglobin and other clinically significant haemoglobins|
|Interpretation of results|
MATERIAL PROVIDED: Dried blood spot specimens prepared from human umbilical cord blood
DISTRIBUTIONS PER YEAR: 12
SAMPLES PER DISTRIBUTION: 3
FREQUENCY OF DISTRIBUTION: Monthly as per the published Distribution Schedule
PROGRAMME OF ANALYSIS:
Online operation for entry of results and return of reports.
Data is analysed against the consensus of participants' results.
For information on Performance Scoring and Monitoring see the UK NEQAS Haematology Participants' Manual which is available to download from www.ukneqash.org.
UK NEQAS Haematology is the expert centre within the UK National External Quality Assessment Service (UK NEQAS) for all aspects of Haematology diagnostic testing external quality assessment (EQA), with almost 5,000 UK and international registrations and a further 3,000 individual practitioners in our educational morphology programme. UK NEQAS Haematology provides a wide range of EQA services for automated cell counting, blood morphology, haemoglobinopathies and other inherited red cell disorders. Participants may select the combination that fits their laboratory profile, making the Scheme flexible and adaptable to participants’ needs.